Skip to main content
Fig. 11 | Cancer Cell International

Fig. 11

From: ncRNAs-mediated overexpression of STIL predict unfavorable prognosis and correlated with the efficacy of immunotherapy of hepatocellular carcinoma

Fig. 11

Relationship between the expression of STIL and several promising immunotherapeutic targets via the TIMER database. A–F The scatterplots of correlation between STIL expression and the promising immunotherapeutic targets (CD274, PDCD1, CTLA-4, LAG3, HAVCR2, and CD47. G The levels of promising immunotherapeutic targets between the high- and low-STIL expression groups

Back to article page